[1]
|
嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36: 737-750. |
[2]
|
Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979[J]. Mayo Clin Proc, 1983, 58: 802-804. http://www.ncbi.nlm.nih.gov/pubmed/6645626 |
[3]
|
McNeil AR, Blok BH, Koelmeyer TD, et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland[J]. Aust N Z J Med, 2000, 30: 648-652. doi: 10.1111/j.1445-5994.2000.tb04358.x |
[4]
|
Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series[J]. Mayo Clin Proc, 1981, 56: 354-360. http://europepmc.org/abstract/med/6453259 |
[5]
|
Scoazec JY, Couvelard A, Réseau TENpath. Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J]. Ann Pathol, 2017, 37: 444-456. doi: 10.1016/j.annpat.2017.10.003 |
[6]
|
Abdelhady K, Durgam S, Orza D, et al. Left Atrial and Carotid Body Paraganglioma[J]. Ann Thorac Surg, 2017, 103: e323-e325. doi: 10.1016/j.athoracsur.2016.09.062 |
[7]
|
Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients[J]. J Clin Endocrinol Metab, 2001, 86: 5210-5216. doi: 10.1210/jcem.86.11.8034 |
[8]
|
Al-Harthy M, Al-Harthy S, Al-Otieschan A, et al. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas[J]. Endocr Pract, 2009, 15: 194-202. doi: 10.4158/EP.15.3.194 |
[9]
|
Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification[J]. Endocr Pathol, 2012, 23: 4-14. doi: 10.1007/s12022-011-9188-1 |
[10]
|
Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors[J]. Endocr Pathol, 2005, 16: 23-32. doi: 10.1385/EP:16:1:023 |
[11]
|
Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases[J]. Am J Surg Pathol, 2002, 26: 551-566. doi: 10.1097/00000478-200205000-00002 |
[12]
|
Strong VE, Kennedy T, Al-Ahmadie H, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis[J]. Surgery, 2008, 143: 759-768. doi: 10.1016/j.surg.2008.02.007 |
[13]
|
de Wailly P, Oragano L, Radé F, et al. Malignant pheochromocytoma: new malignancy criteria[J]. Langenbecks Arch Surg, 2012, 397: 239-246. doi: 10.1007/s00423-011-0850-3 |
[14]
|
Agarwal A, Mehrotra PK, Jain M, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?[J]. World J Surg, 2010, 34: 3022-3028. doi: 10.1007/s00268-010-0744-5 |
[15]
|
Chen H, Sippel RS, O'Dorisio MS, et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer[J]. Pancreas, 2010, 39: 775-783. doi: 10.1097/MPA.0b013e3181ebb4f0 |
[16]
|
Boedeker CC, Neumann HP, Offergeld C, et al. Clinical features of paraganglioma syndromes[J]. Skull Base, 2009, 19: 17-25. doi: 10.1055/s-0028-1103123 |
[17]
|
Shen WT, Grogan R, Vriens M, et al. One Hundred Two Patients With Pheochromocytoma Treated at a Single Institution Since the Introduction of Laparoscopic Adrenalectomy[J]. Arch Surg, 2010, 145: 893-897. doi: 10.1001/archsurg.2010.159 |
[18]
|
Huang KH, Chung SD, Chen SC, et al. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute[J]. Int J Urol, 2007, 14: 181-185. doi: 10.1111/j.1442-2042.2007.01687.x |
[19]
|
Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management[J]. Pediatr Nephrol, 2020, 35: 581-594. doi: 10.1007/s00467-018-4181-2 |
[20]
|
Bholah R, Bunchman TE. Review of Pediatric Pheochromocytoma and Paraganglioma[J]. Front Pediatr, 2017, 5: 155. doi: 10.3389/fped.2017.00155 |